Toy V E, Uslu M O
Department of Periodontology, Faculty of Dentistry, Inonu University, Malatya, Turkey.
Niger J Clin Pract. 2020 Feb;23(2):147-153. doi: 10.4103/njcp.njcp_295_19.
The aim of this study was to examine long-term implant success and marginal bone loss (MBL) of dental implants in postmenopausal women with osteoporosis/osteopenia.
Postmenopausal women who underwent dental implant treatment at least 3 years ago were divided into two study groups [Test (osteoporosis/osteopenia) Group and Control Group] according to bone mineral density (BMD) measurements. Besides clinical periodontal and radiographic examinations, any implant failures were also recorded.
A total of 52 patients with a mean age of 59.51 ± 5.66 years (Test Group; 26 patients, mean age: 60.61; Control Group; 26 patients, mean age: 58.42) were included in the study. Implant survival rates were 96.2% and 100% with a mean follow-up 60.84 ± 22.13 and 60.07 ± 20.93 months in Test and Control Groups, respectively (P > 0.05). While peri-implant PI (plaque index) and PD (probing depth) were not different between the groups, BoP (bleeding on probing) was significantly higher in Test Group (P = 0,026). Although MBL in Test Group was higher than Control Group (0.82 ± 0,63 mm and 0.44 ± 0,33 mm respectively), the difference was not found statistically significant (P = 0.069).
Within the limits of this retrospective study, it can be concluded that postmenopausal osteoporosis/osteopenia does not affect MBL and long-term implant success. The findings suggest that dental implant therapy is a reliable treatment modality in these patients to improve the quality of life by increasing function and aesthetics.
本研究旨在调查患有骨质疏松症/骨质减少症的绝经后女性牙种植体的长期成功率及边缘骨吸收(MBL)情况。
根据骨密度(BMD)测量结果,将至少在3年前接受牙种植治疗的绝经后女性分为两个研究组[试验(骨质疏松症/骨质减少症)组和对照组]。除了进行临床牙周和影像学检查外,还记录了所有种植失败情况。
共有52例患者纳入本研究,平均年龄为59.51±5.66岁(试验组;26例患者,平均年龄:60.61岁;对照组;26例患者,平均年龄:58.42岁)。试验组和对照组的种植体存活率分别为96.2%和100%,平均随访时间分别为60.84±22.13个月和60.07±20.93个月(P>0.05)。虽然两组间种植体周围的菌斑指数(PI)和探诊深度(PD)无差异,但试验组的探诊出血(BoP)明显更高(P=0.026)。虽然试验组的边缘骨吸收高于对照组(分别为0.82±0.63mm和0.44±0.33mm),但差异无统计学意义(P=0.069)。
在本回顾性研究的范围内,可以得出结论,绝经后骨质疏松症/骨质减少症不影响边缘骨吸收和种植体的长期成功率。研究结果表明,牙种植治疗是这些患者可靠的治疗方式,可通过增加功能和美观度来提高生活质量。